Value of Genetic Testing for Cardiomyopathies and Heart Failure: Optimizing a Case-Based Approach

A workshop focusing on the need for genetic testing within cardiomyopathies will be facilitated by Rocket Pharmaceuticals. Clinical practice considerations, operational aspects including genetic testing inquiry, and key points on patient result delivery will be highlighted throughout this session in its entirety. There will be three case-based mini-sessions after the introductory presentation and main overview discussion. Each case will have an activity surrounding one of three different phenotypic presentations (dilated cardiomyopathy, arrhythmogenic cardiomyopathy, and hypertrophic cardiomyopathy).

Sponsored by Rocket Pharmaceuticals